CoreFirst Bank & Trust’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-522
Closed -$8.27K 306
2025
Q3
$8.27K Hold
522
﹤0.01% 302
2025
Q2
$5.98K Buy
+522
New +$5.88K ﹤0.01% 320
2025
Q1
Sell
-522
Closed -$8.82K 151
2024
Q4
$8.82K Hold
522
0.01% 315
2024
Q3
$10.6K Buy
+522
New +$10.7K 0.01% 300
2024
Q2
Sell
-522
Closed -$13.7K 160
2024
Q1
$13.7K Hold
522
0.01% 292
2023
Q4
$16.5K Hold
522
0.01% 286
2023
Q3
$14.6K Sell
522
-159
-23% -$5.46K 0.01% 309
2023
Q2
$25.1K Sell
681
-160
-19% -$4.88K 0.02% 261
2023
Q1
$25.2K Hold
841
0.02% 265
2022
Q4
$25.8K Hold
841
0.02% 282
2022
Q3
$21K Sell
841
-28
-3% -$924 0.02% 279
2022
Q2
$28K Buy
869
+28
+3% +$1.03K 0.02% 256
2022
Q1
$26K Hold
841
0.02% 297
2021
Q4
$29K Hold
841
0.02% 305
2021
Q3
$24K Hold
841
0.02% 330
2021
Q2
$29K Hold
841
0.02% 317
2021
Q1
$24K Sell
841
-39
-4% -$1.04K 0.02% 326
2020
Q4
$22K Buy
+880
New +$20.9K 0.02% 299

Other funds holding CC

CoreFirst Bank & Trust's CC Position: Q4 2025 in Review

CoreFirst Bank & Trust sold out of Chemours (CC) in Q4 2025, closing a stake of 522 shares — an estimated $8.27K sold.

CoreFirst Bank & Trust first reported a position in CC in Q4 2020 and held it in 18 quarters. The position peaked at $29K in Q4 2021. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • CoreFirst Bank & Trust reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • CoreFirst Bank & Trust sold 522 Chemours shares in Q4 2025, an estimated $8.27K.
  • CoreFirst Bank & Trust first reported a position in Chemours in Q4 2020 and held it in 18 quarters.
  • CoreFirst Bank & Trust's Chemours position peaked at $29K in Q4 2021.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on CoreFirst Bank & Trust's 13F filing for Q4 2025, filed 11 Feb 2026.